Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Nov 7, 2015 at 9:25 AM EST

5 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, while others had serious falls.

Chris Lange | Nov 6, 2015 at 8:40 AM EST

Humana Maintains Outlook With Aetna Merger in Sight

Humana reported mixed third-quarter financial results before the markets opened on Friday.

Lee Jackson | Nov 6, 2015 at 8:25 AM EST

Wall Street Hammered These 3 Biotech Stocks: Are They Really Screaming Buys?

We combed through the Merrill Lynch database and found three biotech companies that at one time or another, when they…

Jon C. Ogg | Nov 5, 2015 at 1:15 PM EST

CDC Reports Continued Drop in Number of Uninsured Americans

In terms of health coverage, the number of uninsured Americans is dropping, according to the Centers for Disease Control and…

Chris Lange | Nov 4, 2015 at 1:40 PM EST

What to Expect From Celgene Earnings

Celgene is scheduled to report its third-quarter financial results before the markets open on Thursday.

Jon C. Ogg | Nov 4, 2015 at 1:35 PM EST

Why RBC Is Now So Negative Against MannKind

RBC Capital Markets downgraded MannKind on Wednesday to Underperform from a Market Perform, with a price target of a mere…

Jon C. Ogg | Nov 4, 2015 at 12:50 PM EST

Why Cara Therapeutics Shares Could Potentially Double

A Janney Capital Markets research report on Cara Therapeutics noted a fair value estimate that suggests upside of 82%.

Chris Lange | Nov 3, 2015 at 11:45 AM EST

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

The health care sector may have sold off a fair amount since this past summer, but there is some M&A…

Chris Lange | Nov 2, 2015 at 3:30 PM EST

Wave Life Sciences Sets Terms for IPO

Wave Life Sciences has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial…

Paul Ausick | Nov 2, 2015 at 12:20 PM EST

Dyax Agrees to $5.9 Billion Buyout

Shire and Dyax announced Monday morning that former will acquire latter for almost $6 billion.

Chris Lange | Nov 2, 2015 at 10:10 AM EST

Axsome Therapeutics Sets Terms for IPO

Axsome Therapeutics expects to price more than 4 million shares in the range of $11 to $13 in an IPO…

Chris Lange | Nov 2, 2015 at 8:40 AM EST

Ellipse Technologies Prepares for IPO

The IPO for Ellipse Technologies, a medical technology company focused on revolutionizing orthopedic surgery, is valued up to $75 million.

Chris Lange | Nov 1, 2015 at 9:10 AM EST

4 Key FDA Decisions Expected in November and December

24/7 Wall St. has collected several big FDA decisions coming up in the month of November.

Chris Lange | Oct 31, 2015 at 10:10 AM EDT

6 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, and some had serious falls.

Chris Lange | Oct 30, 2015 at 11:40 AM EDT

Medical Tourism Expected to Triple by 2019

Medical tourism has become increasingly popular in recent years as we see the globalization of modern medicine take off, as…

1 … 235 236 237 238 239 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

5 BioPharma Movers That Cannot Be Ignored

Humana Maintains Outlook With Aetna Merger in Sight

Wall Street Hammered These 3 Biotech Stocks: Are They Really Screaming Buys?

CDC Reports Continued Drop in Number of Uninsured Americans

What to Expect From Celgene Earnings

Why RBC Is Now So Negative Against MannKind

Why Cara Therapeutics Shares Could Potentially Double

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

Wave Life Sciences Sets Terms for IPO

Dyax Agrees to $5.9 Billion Buyout

Axsome Therapeutics Sets Terms for IPO

Ellipse Technologies Prepares for IPO

4 Key FDA Decisions Expected in November and December

6 BioPharma Movers That Cannot Be Ignored

Medical Tourism Expected to Triple by 2019

Bitcoin Price: BTC Just Reclaimed the Bull Market Support Band for the First Time in 6 Months

ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Bitcoin Price: BTC Just Reclaimed the Bull Market Support Band for the First Time in 6 Months

ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40

Health and Healthcare Articles

All Health and Healthcare Articles

5 BioPharma Movers That Cannot Be Ignored

Humana Maintains Outlook With Aetna Merger in Sight

Wall Street Hammered These 3 Biotech Stocks: Are They Really Screaming Buys?

CDC Reports Continued Drop in Number of Uninsured Americans

What to Expect From Celgene Earnings

Why RBC Is Now So Negative Against MannKind

Why Cara Therapeutics Shares Could Potentially Double

Why 2 Analysts Are Talking Up a Pfizer-Allergan Merger

Wave Life Sciences Sets Terms for IPO

Dyax Agrees to $5.9 Billion Buyout

Axsome Therapeutics Sets Terms for IPO

Ellipse Technologies Prepares for IPO

4 Key FDA Decisions Expected in November and December

6 BioPharma Movers That Cannot Be Ignored

Medical Tourism Expected to Triple by 2019

Bitcoin Price: BTC Just Reclaimed the Bull Market Support Band for the First Time in 6 Months

ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how